Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Single Dose rATG for Treatment of Acute Renal Allograft Rejection

NCT02102854 is registered in ClinicalTrials.gov with The Methodist Hospital Research Institute as lead sponsor.

NCT NCT02102854
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02102854 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Single Dose rATG for Treatment of Acute Renal Allograft Rejection
Lead sponsor
The Methodist Hospital Research Institute
Phase
Phase 4
Overall status
Unknown status
Start date
March 31, 2014
Completion date
October 31, 2021
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute (cellular) renal allograft rejection